Invention Grant
- Patent Title: Immunoregulatory agents
-
Application No.: US17552517Application Date: 2021-12-16
-
Publication No.: US11932601B2Publication Date: 2024-03-19
- Inventor: Hilary Plake Beck , Juan Carlos Jaen , Maksim Osipov , Jay Patrick Powers , Maureen Kay Reilly , Hunter Paul Shunatona , James Ross Walker , Mikhail Zibinsky , James Aaron Balog , David K. Williams , Weiwei Guo
- Applicant: FLEXUS BIOSCIENCES, INC.
- Applicant Address: US NJ Princeton
- Assignee: Flexus Biosciences, Inc.
- Current Assignee: Flexus Biosciences, Inc.
- Current Assignee Address: US NJ Princeton
- Agency: BakerHostetler
- Main IPC: C07D213/75
- IPC: C07D213/75 ; A61K31/167 ; A61K31/195 ; A61K31/277 ; A61K31/343 ; A61K31/426 ; A61K31/44 ; A61K31/505 ; A61K31/5375 ; A61K39/39 ; A61K45/06 ; A61P35/00 ; A61P37/06 ; C07C233/11 ; C07C233/15 ; C07C233/28 ; C07C233/29 ; C07C233/66 ; C07C235/26 ; C07C235/36 ; C07C235/38 ; C07C237/20 ; C07C237/22 ; C07C255/57 ; C07C255/60 ; C07C317/40 ; C07C317/44 ; C07C321/28 ; C07C323/41 ; C07D207/27 ; C07D213/56 ; C07D231/12 ; C07D239/42 ; C07D277/30 ; C07D295/15 ; C07D295/155 ; C07D309/04 ; C07D309/06 ; C07D317/46 ; C07D317/66 ; A61K39/00
Abstract:
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
Public/Granted literature
- US20220274926A1 IMMUNOREGULATORY AGENTS Public/Granted day:2022-09-01
Information query
IPC分类:
